Cel-Sci
CVM
#9766
Rank
โ‚น4.63 B
Marketcap
โ‚น579.44
Share price
2.54%
Change (1 day)
-59.27%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -โ‚น2.11 Billion

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น2.39 Billion, an increase over its 2023 earnings that were of -โ‚น2.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.11 Billion-11.72%
2024 -โ‚น2.39 Billion-12.41%
2023 -โ‚น2.73 Billion-12.87%
2022 -โ‚น3.13 Billion-3.42%
2021 -โ‚น3.24 Billion13.44%
2020 -โ‚น2.86 Billion11.28%
2019 -โ‚น2.57 Billion179.81%
2018 -โ‚น0.92 Billion-48.72%
2017 -โ‚น1.79 Billion-16.23%
2016 -โ‚น2.14 Billion-23.63%
2015 -โ‚น2.8 Billion-5.47%
2014 -โ‚น2.96 Billion198.49%
2013 -โ‚น1 Billion
2010 -โ‚น1.16 Billion
2004 -โ‚น0.4 Billion12.38%
2003 -โ‚น0.35 Billion-16.59%
2002 -โ‚น0.42 Billion-59.28%
2001 -โ‚น1.03 Billion23.17%
2000 -โ‚น0.84 Billion20.12%
1999 -โ‚น0.7 Billion13.24%
1998 -โ‚น0.62 Billion-20%
1997 -โ‚น0.77 Billion46.55%
1996 -โ‚น0.53 Billion34.88%
1995 -โ‚น0.39 Billion2.38%
1994 -โ‚น0.38 Billion68%
1993 -โ‚น0.23 Billion78.57%
1992 -โ‚น0.13 Billion180%
1991 -โ‚น44.92 Million25%
1990 -โ‚น35.94 Million-0%
1989 -โ‚น35.94 Million-71.43%
1988 -โ‚น0.13 Billion-0%
1987 -โ‚น0.13 Billion-46.15%
1986 -โ‚น0.24 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-โ‚น2.93 Billion 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น0.6 Billion-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น740.61 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น12.4 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น159.19 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚น2.910 T-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น14.84 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.86 Billion-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA